| 763718 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
570 Blockade of the inhibitory collagen receptor LAIR-1, PD-L1, and TGF-β promotes anti-tumor activity through T cell activation and myeloid cell polarization |
2021-11-01 |
10.1136/jitc-2021-sitc2021.570 |
Horn Lucas, Qin Haiyan, Fousek Kristen, Iida Masafumi, Flies Dallas, Copeland Ronald, Cusumano Zachary, Myint Han, Langermann Solomon, Schlom Jeffrey, Palena Claudia |
| 763717 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
623 Notch orchestrates a multifaceted immune evasion program in hepatocellular carcinoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.623 |
Lindblad Katherine, Galarreta Marina Ruiz de, Donne Romain, Bárcena-Varela Marina, Liebling Ian, Repáraz David, Yao Melissa, Dhainaut Maxime, Brown Brian, Kamphorst Alice, Lujambio Amaia |
| 763716 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
518 First-in-human results with the novel tumor-targeting antibody ATRC-101: phase 1b study in patients with solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.518 |
Powderly John, Jones Jeremy, Bekaii-Saab Tanios, Xing Yan, John Weroha S, Ulahannan Susanna, Doroshow Deborah, Valdes-Albini Frances, Millward Carl, Walter Kimberly, Wrong Andrew, Castillo Paul Del, Wang Lixia, Nguyen Ngan, Whidden Mark, Benjamin Jonathan, Isakoff Steven |
| 763715 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
499 A first-in-human, phase 1/2 clinical trial of TK-8001, a MAGE-A1 directed T cell receptor in patients with advanced-stage solid tumors (The “IMAG1NE”-trial) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.499 |
Thistlethwaite Fiona, Busse Antonia, Calvo Emiliano, Goebeler Marie-Luise, Wermke Martin, Rottey Sylvie, Kotecki Nuria, Obenaus Matthias, Scheuplein Vivian, Wolter Ralf, Perdomo-Ortiz Carolina, Gavvovidis Ioannis, Kieback Elisa, Blankenstein Thomas, Leo Eugen |
| 763714 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
185 Ex vivo efficacy of adoptive T cell therapy using autologous CD8+ T cells isolated by PD-1 positivity from peripheral blood mononuclear cells in solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.185 |
Lee Sungkyu, Moon Yong Wha |
| 763713 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
449 Concurrent ibrutinib enhances T cell function in patients with chronic lymphocytic leukemia (CLL) treated with lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T cell therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.449 |
Thorpe Jerill, Rytlewski Julie, Gillenwater Heidi, Ogasawara Ken, Kim Yeonhee, Shpektor Diana, Papp Eniko, Peiser Leanne |
| 763712 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
160 Evaluation and development of dual and triple antigen targeting CAR-T Engager proteins for Her2-positive CNS metastases and solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.160 |
Rennert Paul, Wu Lan, Su Lihe, Lobb Roy, Ambrose Christine |
| 763711 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
309 Visualizing the immunotherapy-induced spatial reorganization of the tumor-immune microenvironment by CODEX multiplex imaging |
2021-11-01 |
10.1136/jitc-2021-sitc2021.309 |
Medrano Ruan, Han Fei, Cheikh Bassem Ben, Leinert Patrick, Leinert Wm Pat, Braubach Oliver, Schreiber Robert |
| 763710 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
747 CodaLytic™, a novel codon-pair deoptimized influenza virus creates an immune-stimulatory tumor microenvironment leading to monotherapy efficacy in a preclinical model of breast cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.747 |
Stawowczyk Marcin, Pfeffer Katie, Tafrova Juliana, Stauft Charles, Kushnir Anna, Tasker Sybil, Mueller Steffen, Robert Coleman J, Kaufmann Johanna |
| 763709 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
773 A novel cancer immunotherapy; vaccination against tumor vascular extracellular vimentin |
2021-11-01 |
10.1136/jitc-2021-sitc2021.773 |
Huijbers Elisabeth, Beijnum Judy van, Loon Karlijn van, Griffioen Arjan |
